EUVIMEDEUVIMED entdecken
Crossref

Cisplatin Neoadjuvant Chemotherapy in an Aging Population With Muscle-Invasive Bladder Cancer

Jun Gong

ONCOLOGY · 2022

DOI: 10.46883/2022.25920941 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ONCOLOGY, 2022. Verfasst von Jun Gong. Beteiligte Einrichtung: Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai, Los Angeles, CA.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AgedAntineoplastic AgentsCisplatinCystectomyDisease-Free SurvivalFemaleHumansMaleMuscle NeoplasmsNeoadjuvant TherapyNeoplasm InvasivenessRetrospective StudiesTime FactorsUrinary BladderUrinary Bladder Neoplasms

Substanzen

Antineoplastic AgentsCisplatin

Autor:innen und Institutionen

  • Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai, Los Angeles, CA.

Zitieren

APA

Gong, J. (2022). Cisplatin Neoadjuvant Chemotherapy in an Aging Population With Muscle-Invasive Bladder Cancer. ONCOLOGY. https://doi.org/10.46883/2022.25920941

Vancouver

Gong J. Cisplatin Neoadjuvant Chemotherapy in an Aging Population With Muscle-Invasive Bladder Cancer. ONCOLOGY. 2022. doi:10.46883/2022.25920941

BibTeX
@article{Gong2022,
  author = {Gong, Jun},
  title = {Cisplatin Neoadjuvant Chemotherapy in an Aging Population With Muscle-Invasive Bladder Cancer},
  journal = {ONCOLOGY},
  year = {2022},
  doi = {10.46883/2022.25920941}
}
Kostenlos starten →